31.72
-0.35 (-1.09%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Bearish |
| Health Information Services (Global) | Bearish | Bearish | |
| Stock | Progyny, Inc. | Bearish | Bearish |
Analyst Consensus
7 Buy
Avg. Price @ Call: 30.08
|
Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Growth |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Kpcb Xiii Associates, Llc | 30 Sep 2023 | 5,074,615 |
| 52 Weeks Range |
29.44 - 44.95
|
|
| Price Target Range | ||
| High | 49.00 (Leerink Partners, 54.48%) | Buy |
| Median | 43.00 (35.56%) | |
| Low | 30.00 (Barclays, -5.42%) | Buy |
| Average | 42.00 (32.41%) | |
| Total | 7 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Truist Securities | 17 May 2024 | 37.00 (16.65%) | Buy | 26.78 |
| 17 Apr 2024 | 46.00 (45.02%) | Buy | 32.75 | |
| Cantor Fitzgerald | 16 May 2024 | 48.00 (51.32%) | Buy | 26.78 |
| 28 Feb 2024 | 48.00 (51.32%) | Buy | 34.65 | |
| Barclays | 13 May 2024 | 30.00 (-5.42%) | Buy | 27.40 |
| BTIG | 10 May 2024 | 41.00 (29.26%) | Buy | 27.53 |
| Canaccord Genuity | 10 May 2024 | 37.00 (16.65%) | Buy | 27.53 |
| Keybanc | 28 Feb 2024 | 43.00 (35.56%) | Buy | 34.65 |
| Leerink Partners | 26 Feb 2024 | 49.00 (54.48%) | Buy | 39.87 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 14 May 2024 | Announcement | Progyny, Inc. to Present at BofA Securities 2024 Healthcare Conference and Leerink Partners Healthcare Crossroads Conference 2024 |
| 09 May 2024 | Announcement | Progyny, Inc. Announces First Quarter 2024 Results |
| 25 Apr 2024 | Announcement | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report |
| 17 Apr 2024 | Announcement | Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care |
| 04 Apr 2024 | Announcement | Progyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast |
| 18 Mar 2024 | Announcement | Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum |
| 11 Mar 2024 | Announcement | Progyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference |
| 29 Feb 2024 | Announcement | Progyny, Inc. Announces Share Repurchase Program |
| 27 Feb 2024 | Announcement | Progyny, Inc. Announces Fourth Quarter 2023 Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |